Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys: 451 trades; $10.3T in total
Open-market sales: 843 trades; $1.1B in total
Insiders filing: 399 insiders; Last 7 days
Companies with several buyers: 28; Last 7 days

		Trade type
John S. MontalbanoDirector	AbCellera BiologicsABCL	Open-market buy	05/14	05/18	20,000 sh	$4.77	$95,400	+9.0%
Thermopylae Holdings10% Owner	AbCellera BiologicsABCL	Open-market buy	02/27	03/02	38,000 sh	$3.44	$130,720	+0.1%
Andrew BoothCFO	AbCellera BiologicsABCL	Open-market buy	02/27	02/27	42,600 sh	$3.42	$145,692	+27.8%
Thermopylae Holdings10% Owner	AbCellera BiologicsABCL	Open-market buy	02/26	02/27	177,457 sh	$3.27	$580,284.39	+0.3%
John S. MontalbanoDirector	AbCellera BiologicsABCL	Open-market buy	25/11/26	25/11/26	50,000 sh	$3.57	$178,500	+29.2%
Thermopylae Holdings10% Owner	AbCellera BiologicsABCL	Open-market buy	25/03/11	25/03/11	343,631 sh	$2.16	$742,242.96	+0.6%
John S. MontalbanoDirector	AbCellera BiologicsABCL	Open-market buy	25/03/10	25/03/10	25,000 sh	$2.30	$57,500	+17.1%
John S. MontalbanoDirector	AbCellera BiologicsABCL	Open-market buy	25/03/06	25/03/07	60,000 sh	$2.34	$140,400	+69.8%
Thermopylae Holdings10% Owner	AbCellera BiologicsABCL	Open-market buy	24/08/29	24/08/29	283,516 sh	$2.61	$739,976.76	+0.5%
Director	AbCellera BiologicsABCL	Open-market buy	23/11/06–23/11/08	23/11/08	30,000 sh2 trades	$4.58avg.	$137,400	+53.6%
Michael R. HaydenDirector	AbCellera BiologicsABCL	Open-market buy	23/09/22	23/09/26	20,000 sh	$4.91	$98,200	+1.5%
Veronique LecaultCOO	AbCellera BiologicsABCL	Open-market buy	23/09/12	23/09/14	20,000 sh	$5.19	$103,800	+1.0%
Michael R. HaydenDirector	AbCellera BiologicsABCL	Open-market buy	23/08/08	23/08/09	30,000 sh	$5.90	$177,000	+2.4%
Andrew BoothCFO	AbCellera BiologicsABCL	Open-market buy	23/05/26	23/05/26	14,500 sh	$6.85	$99,325	+10.5%
Thermopylae Holdings10% Owner	AbCellera BiologicsABCL	Open-market buy	23/05/26	23/05/26	153,000 sh	$6.52	$997,560	+0.3%